KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Non-Current Deferred Tax Liability (2016 - 2025)

BeOne Medicines (ONC) has disclosed Non-Current Deferred Tax Liability for 10 consecutive years, with $47.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 195.36% to $47.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $47.1 million, a 195.36% increase, with the full-year FY2024 number at $42.0 million, up 108.9% from a year prior.
  • Non-Current Deferred Tax Liability was $47.1 million for Q3 2025 at BeOne Medicines, up from $44.1 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $47.1 million in Q3 2025 to a low of $10.8 million in Q1 2021.
  • A 5-year average of $21.2 million and a median of $15.9 million in 2024 define the central range for Non-Current Deferred Tax Liability.
  • Peak YoY movement for Non-Current Deferred Tax Liability: decreased 2.59% in 2024, then surged 195.36% in 2025.
  • BeOne Medicines' Non-Current Deferred Tax Liability stood at $14.2 million in 2021, then rose by 12.89% to $16.0 million in 2022, then increased by 25.71% to $20.1 million in 2023, then surged by 108.9% to $42.0 million in 2024, then increased by 12.04% to $47.1 million in 2025.
  • Per Business Quant, the three most recent readings for ONC's Non-Current Deferred Tax Liability are $47.1 million (Q3 2025), $44.1 million (Q2 2025), and $43.1 million (Q1 2025).